New preclinical data on 3D bioprinted human liver tissues presented at World Advanced Therapies and Regenerative Medicine Congress

Data demonstrating extended survival and sustained functionality of tissue produced utilizing 3D bioprinting was presented at the World Advanced Therapies and Regenerative Medicine Congress. 3D bioprinted tissue has been demonstrated to have extended survival and sustained functionality when implanted into a diseased animal model. In the data, presented by Benjamin Sheperd, Director of Therapeutics, Organovo (CA, USA) at World Advanced Therapies and Regenerative Medicine Congress (London, UK; 17-18 May), was from a study utilizing an established model for alpha-one-antitrypsin deficiency. “With tens of thousands of patients being treated for inborn errors of metabolism (IEMs) in the USA and an annual...